Modelling alternative strategies for delivering hepatitis B vaccine in prisons : the impact on the vaccination coverage of the injecting drug user population [PDF]
, 2008 Since 2001 hepatitis B vaccination has been offered to prisoners on reception into prisons in England and Wales. However, short campaigns of vaccinating the entire population of individual prisons have achieved high vaccination coverage for limited ...
Sutton, AJ +8 more
core +1 more source
Protective response of bivalent brucella vaccine with differant adjuvant in mice [PDF]
Benha Veterinary Medical Journal, 2021 Brucellosis is one of the most common bacterial zoonotic diseases. There are two live attenuated vaccines used in control programs, B. abortus S19, B. melitensis rev1 vaccine for cattle,sheep and goat respectively .
Basma mohammed hussien +2 more
doaj +1 more source
Duration of Immunity against Mycobacterium bovis following Neonatal Vaccination with Bacillus Calmette-Guerin Danish: Significant Protection against Infection at 12, but Not 24, Months [PDF]
, 2012 Vaccination of neonatal calves with Mycobacterium bovis bacillus Calmette-Guerin (BCG) induces a significant degree of protection against bovine tuberculosis, caused by infection with virulent M. bovis.
McAulay, M. +6 more
core +1 more source
BMJ Open, 2023 Background Pregnant women, foetuses and infants are at risk of infectious disease-related complications. Maternal vaccination is a strategy developed to better protect pregnant women and their offspring against infectious disease-related morbidity and ...
Pierre Van Damme +5 more
doaj +1 more source
Potential for rabies control through dog vaccination in wildlife-abundant communities of Tanzania [PDF]
, 2012 Canine vaccination has been successful in controlling rabies in diverse settings worldwide. However, concerns remain that coverage levels which have previously been sufficient might be insufficient in systems where transmission occurs both between and ...
Alison P. Galvani (42462) +23 more
core +1 more source
Economic evaluation of human papillomavirus vaccination in the United Kingdom. [PDF]
, 2008 OBJECTIVE: To assess the cost effectiveness of routine vaccination of 12 year old schoolgirls against human papillomavirus infection in the United Kingdom. DESIGN: Economic evaluation. SETTING: UK. Population Schoolgirls aged 12 or older.
Choi, Yoon Hong +2 more
core +1 more source
Italian Journal of Pediatrics, 2019 Background Invasive meningococcal disease is a serious global health threat in the world; in 2016, the European Centre for Disease Control and Prevention reported 3280 confirmed cases (including 304 deaths) of Invasive Meningococcal Diseases in Europe ...
L. Nicolosi +7 more
doaj +1 more source
Physicians’ attitudes towards human papillomavirus vaccination programme: A systematic review [PDF]
, 2011 Human papillomavirus (HPV) vaccine is a newly introduced vaccine against cervical cancer in adolescent girls. Uptake of the vaccine will be dependent on parental acceptability and physician recommendation.
Franco, Maria F.
core +2 more sources
Who invented vaccination? [PDF]
, 2011 Edward Jenner, whose ‘Inquiry’ (1798)1 was the first published report of vaccination against smallpox, is widely seen as the inventor of vaccination. However, other individuals could lay claim to this title, notably his contemporaries, Benjamin Jesty and
Jesty, R +2 more
core
7-Valent pneumococcal conjugate vaccination in England and Wales: is it still beneficial despite high levels of serotype replacement? [PDF]
, 2011 BACKGROUND: The UK introduced the 7-valent pneumococcal conjugate vaccine (PCV7) into the national vaccination program in September 2006. Previous modelling assumed that the likely impact of PCV7 on invasive pneumococcal disease (IPD) would be similar to
Nigel Gay +31 more
core +1 more source